Benzazole derivatives and their use as jnk modulators
CA 2394809 C · Owner: Laboratoires Serono S.A. · Inventors: Gaillard, Pascale; Gotteland, Jean-Pierre; Church, Dennis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is related to benzazole derivatives accord-ing to formula (I) wherein X is O S, or NR O with R0 being H or an , unsubstituted or substituted C1-C6alkyl, and G is an unsubstituted or substituted pyrimidinyl , group, notably for use as pharmaceutically active compounds as well as to , phar-maceutical formulations containing such benzazoles derivatives. Said benzazoles , derivatives are efficient modulators of the JNK pathway they are in , particular , ef-ficient and selective inhibitors of JNK2 and/or 3.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 20, 2000 and granted March 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.